Craig C. Hofmeister

Ohio State University

$2,792,841

Attributed

$5,858,872

Total exposure

Grants

Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $1.2M · FY2011–21

$2M$1.5M$1M$500K$0

'11

'12

'13

'14

'15

'16

'17

'18

'19

'20

'21

Funding mix

By agency

NIH$5,858,872 · 3

By mechanism

R01$5,281,558 · 2

R21$577,314 · 1

Top collaborators

Flavia Pichiorri13 shared
Mitch A Phelps7 shared

Most similar at Ohio State University

Same institution · by research overlap

Flavia Pichiorri$3,617,059
Mitch A Phelps$6,387,631
David P Carbone$20,647,321
Jennifer A. Woyach$6,733,332
Lapo Alinari$4,506,413

Others in their field

Top investigators on “In Vitro”

David Heimbrook · Leidos Biomedical Research, Inc.$553,787,942
Leonard Freedman · Leidos Biomedical Research, Inc.$310,441,779
Mark S Klempner · Tufts Medical Center$128,021,180
Florian Krammer · Icahn School Of Medicine At Mount Sinai$104,723,856
Lynn Briscoe · Leidos Biomedical Research, Inc.$94,686,873
Dennis R. Burton · Scripps Research Institute$79,204,175

Research focus

In VitroPharmaceutical PreparationsIn VivoToxic EffectPreclinical StudyResponseRelapseCombined Modality TherapyMalignant NeoplasmsFutureNeoplastic CellMultiple MyelomaCellsNovel TherapeuticsCell DeathResistanceHematopoietic NeoplasmsHistone Deacetylase InhibitorCancer CellBaseEpigenetic ProcessPhase I Clinical TrialsDose-LimitingMaximum Tolerated Dose